Pharmacy Microsites

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the School’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

Research unearths new details about the protein networks that keep cells healthy

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.